Roche Launches AXELIOS 1 Sequencing Platform to Advance Genomics Research with Innovative SBX Technology Roche has announced the commercial launch of AXELIOS 1, a next-generation sequencing platform powered by its innovative Sequencing by Expansion (SBX) technology. Designed to deliver an…
Epicrispr Biotechnologies Reports Promising Phase 1/2 Data Showing Increased Muscle Volume with EPI-321 in Patients with Facioscapulohumeral Muscular Dystrophy Epicrispr Biotechnologies, a clinical-stage biotechnology company focused on developing epigenetic therapies, has announced encouraging interim results from its ongoing Phase 1/2…
New Reproducibility Standard Set for Breast Imaging Biomarkers QT Imaging Holdings, Inc., a medical device company focused on advancing breast health through radiation-free imaging technology, has reported new data characterizing the repeatability and reproducibility of quantitative imaging biomarkers generated by…
DiaMedica Begins Phase 2 Clinical Evaluation of DM199 in Fetal Growth Restriction as First Patients Receive Treatment DiaMedica Therapeutics has reached an important clinical milestone in its effort to address serious pregnancy-related complications, announcing that the first two patients have…
Trace Neuroscience Launches Global Clinical Development Program for TRCN-1023 in ALS Trace Neuroscience, Inc., a biopharmaceutical company focused on advancing genomic medicine for people living with neurodegenerative diseases, has announced the start of its global clinical development program for TRCN-1023,…
Cataltheia Group Publishes Clinical Data Supporting Deseyne Contact Lens for Presbyopia in Optometry and Vision Science The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, have announced the publication of pivotal clinical data in Optometry and Vision Science…
Astrogen Wins International Psychiatry Honor for Autism Clinical Trial Research, Strengthening Momentum for Speragen’s Global Development Astrogen, Inc., a South Korean biotechnology company focused on developing therapies for neurodevelopmental disorders, has earned international recognition for its autism spectrum disorder clinical…
Oligomerix Receives $1.9 Million NIH Grant to Advance Oral Tau-Targeting Therapy for Alzheimer’s Disease Oligomerix, Inc., a privately held clinical-stage biotechnology company focused on developing novel treatments for Alzheimer’s disease and rare neurodegenerative disorders, has been awarded a $1.9 million…
Deciphera Pharmaceuticals Launches Global Phase 3 INTREPID Trial of Sapablursen for Polycythemia Vera Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd., has announced a significant milestone in the development of a potential new treatment for polycythemia vera (PV), with…
Jazz Pharmaceuticals and AbCellera Partner to Advance Next-Generation T-Cell Engaging Antibodies for Gastrointestinal and Solid Tumors Jazz Pharmaceuticals and AbCellera have entered into a strategic research collaboration aimed at discovering and developing a new generation of T-cell engaging (TCE) multispecific…
BioTools Innovator VANGUARD and BARDA Launch ReadyDetect Competition to Advance At-Home Blood Collection Technologies BioTools Innovator VANGUARD, in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), has announced the launch of the ReadyDetect: Blood Sampling Competition, a new…
Pelago Bioscience Expands Drug Discovery Capabilities Through Acquisition of RG Discovery Pelago Bioscience, a leading contract research organization (CRO) specializing in cell-based target engagement technologies, has announced the acquisition of RG Discovery, a Sweden-based drug discovery company recognized for its…